Clinical Trial News
Most Popular Clinical Trial Story
Why was the Niaspan vs. Zetia trial stopped?
Yes, folks, we have another cholesterol-drug trial mystery on our hands. A study comparing Abbott's Niaspan drug with Merck/Schering-Plough's Zetia was terminated by an independent steering Read more...
Latest Headlines
- February 9, 2011
- October 18, 2010
- August 6, 2010
- February 2, 2010
- August 14, 2009
- July 13, 2009
- July 9, 2009
- June 17, 2009
- June 16, 2009
- March 25, 2009
- December 19, 2008
- December 15, 2008
- November 26, 2008
- November 21, 2008
- November 17, 2008
- October 21, 2008
- October 17, 2008
- October 16, 2008
- September 22, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
